Extracellular biosynthesis, OVAT/statistical optimization, and characterization of silver nanoparticles (AgNPs) using Leclercia adecarboxylata THHM and its antimicrobial activity

Table 3 Measurements of clear zones obtained by bio-AgNPs and different commercially antibiotics against seven human pathogenic microbes

Microbial strain	Clear zone (mm)
	bio-AgNPs	Antibiotic
	bio-AgNPs	GEN	AMP	CTR	VA	CIP	TE
Staphylococcus aureus ATCC6538	14	16	36	0	26	26	34
Bacillus cereus ATCC6633	12	16	36	0	26	30	36
Escherichia coli NCTC10418	12	16	36	0	26	30	34
Vibrio cholera ATCC700	16	16	34	15	24	30	34
Pseudomonas aeruginosa ATCC9027	10	18	34	0	26	30	33
Klebsiella pneumoniae ATCC13883	14	16	38	22	22	32	10
Candida albicans ATCC 700	12	16	36	12	24	26	35

Where bio-AgNPs biosynthesized AgNPs, GEN gentamicin (10 µg), AMP ampicillin (10 µg), CTR ceftriaxone (30 µg), VA vancomycin (30 µg), CIP ciprofloxacin (5 µg), and TE tetracycline (30 µg)

ISSN: 1475-2859